ClinicalTrials.gg
Status unknownNCT06496698Updated Jul 11, 2024

Impact of Suture Technique on Wound Healing in Ankle Fracture Surgery: A Randomized Controlled Trial

An interventional study of Simple Interrupted Suture and Subcuticular Suture in Ankle Fractures, sponsored by University of Puerto Rico. Status unknown. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2024-07-11.

Sponsored by University of Puerto Rico · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Our primary aim is to compare the complication rates of patients with ankle fractures who underwent skin closure using a running subcuticular suture pattern compared to an interrupted suture pattern. At the time of the operation, participants will be assigned to either the Subcuticular Suture Group (SSG) or the Simple Interrupted Suture Group (SISG) using computer-generated randomization programs. The surgeon will perform the assigned closure technique using standardized techniques. Running subcuticular Vicryl 3-0 sutures will be placed on patients in the experimental group while simple interrupted Monocryl 3-0 sutures patients in our control group.

Patients will be followed up at the two-week and eight-week postoperative mark where we will use the Patient and Observer Scar Assessment Scale (POSAS) to evaluate and compare wound healing. Additionally, photographs of the scars will be captured to visually assess the healing progression.

02

Conditions studied

  • Ankle Fractures

Browse trials for

03

In context

Ankle Fractures

202 studies on the registry are indexed under Ankle Fractures; 44 are open to participants now.

This study's planned enrollment of 80 is below the median of 90 across 150 interventional studies indexed under Ankle Fractures.

Browse Ankle Fractures studies →

Lead sponsor

University of Puerto Rico is the lead sponsor of 46 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 21 years or older with isolated ankle fractures requiring surgical intervention and who consent to participate.

Exclusion criteria

Exclusion Criteria:

  • Patients that will be excluded from this study include those with complex ankle fractures, open fractures, a history of wound healing disorders, and/or those unable to provide consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Subcuticular Suture Group

    Running subcuticular Vicryl 3-0 sutures will be placed on patients in the experimental group.

    Procedure: Subcuticular Suture

  • Active comparator
    Simple Interrupted Suture Group

    Simple interrupted Monocryl 3-0 sutures will be placed on patients in the control group.

    Procedure: Simple Interrupted Suture

Interventions

  • ProcedureSimple Interrupted Suture

    In the control group, simple interrupted sutures will be used for wound closure after surgical repair of ankle fractures.

  • ProcedureSubcuticular Suture

    In the experimental group, subcuticular sutures will be used for wound closure after surgical repair of ankle fractures.

06

What researchers measure

Primary outcomes

  1. Postoperative Complication rates

    Complications include wound infection, dehiscence, suture breakage, suture abscess, necrosis, allergic reactions, malunion, hardware failure, and the need for reoperation or revision surgery.

    Time frame: 2 and 8 weeks post-op.

Secondary outcomes

  1. Patient and Observer Scar Assessment Scale (POSAS)

    The Patient and Observer Scar Assessment Scale (POSAS) is a comprehensive tool used to evaluate the quality of scars from both the patient's and observer's perspectives. It consists of two parts: the Patient Scale and the Observer Scale.

    Time frame: 2 and 8 weeks post-op.

  2. Self-reported foot and ankle score (SEFAS)

    Consists of 12 items related to pain, limping, swelling, and use of orthotics and walking.

    Time frame: 2 and 8 weeks post-op.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2024; primary completion for Jul 2026, 24 months later.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 24 months is below that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2024
First posted
Jul 11, 2024
StartEst.
Jul 15, 2024
Primary completionEst.
Jul 15, 2026
CompletionEst.
Jul 15, 2026
Last update
Jul 11, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06496698
Lead sponsor
University of Puerto Rico
Responsible party
Sponsor
First posted
Jul 11, 2024
Start date
Jul 15, 2024 (estimated)
Primary completion
Jul 15, 2026 (estimated)
Completion
Jul 15, 2026 (estimated)
Last update
Jul 11, 2024

Study contacts

José Acosta, MD
Contact
jose.acosta14@upr.edu
787-758-2525 ext. 1907
Carlos Guevara, MD
Contact
Carlos.guevara2@upr.edu
787-758-2525‬ ext. 1908

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion